Flamingo Therapeutics
0729.892.237 · rovalta.com · 24/09/2026
NORMAL SITUATION
Flamingo Therapeutics
Company — Normal situation.
Financial year 2025 · Closed on 31/12/2025
Net result
-13,4 M €
-57,4 %over 1 yearEquity
15,8 M €
-45,8 %over 1 yearWorkforce
7,7 ETP
-36,4 %over 1 yearOverview
Identity
Source · BCE/KBOFlamingo Therapeutics is a company registered in Belgium. It employs on average 7,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0729.892.237
- Legal form
- Public limited company
- Contributed capital
- 59 331 771,87 €
- Latest accounts
- 31/12/2025
- Average workforce
- 7,7 ETP
Joint committees (2)
- 207
- 20700
Signals
Solid equityGood liquidityHealthy social debts
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | – | – | -1,3 M € | -1144% | 125,3 k € | -43.5% | 221,7 k € | ||
| EBITDA | -10,8 M € | -435% | -2 M € | +44.1% | -3,6 M € | -417% | -695,5 k € | -167% | -261 k € |
| Operating result | -10,8 M € | +4.3% | -11,2 M € | -1.3% | -11,1 M € | -50.3% | -7,4 M € | -207% | -2,4 M € |
| Net result | -13,4 M € | -57.4% | -8,5 M € | +21.5% | -10,8 M € | -47.2% | -7,3 M € | -204% | -2,4 M € |
| Balance sheet | |||||||||
| Equity | 15,8 M € | -45.8% | 29,1 M € | -22.5% | 37,6 M € | +1317% | -3,1 M € | -173% | 4,2 M € |
| Total assets | 16 M € | -48.5% | 31,1 M € | -20.7% | 39,2 M € | +553% | 6 M € | -54.4% | 13,2 M € |
| Cash | 15,5 M € | +149% | 6,2 M € | -10.2% | 6,9 M € | +41.5% | 4,9 M € | -58.9% | 11,9 M € |
| Debts | 190,9 k € | -71.4% | 667,6 k € | -9.0% | 733,5 k € | -91.7% | 8,9 M € | +0.4% | 8,8 M € |
| Other | |||||||||
| Workforce | 7,7 ETP | -36.4% | 12,1 ETP | -19.9% | 15,1 ETP | +84.1% | 8,2 ETP | +46.4% | 5,6 ETP |
Board of directors
Source · NBB, accounts to 31/12/20258 active · 26 ended
Active mandates
Cohen Ezra
ActiveActive
Bpifrance Investissement SAS
ActiveGemayel Georges
ActiveSkinner Henry
ActiveActive
Mirabelli Christopher
ActiveDroller Rémi
ActiveEnded mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 04/07/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 18 months |
| Filing date | 12/01/2026 | 14/07/2025 | 09/07/2024 | 26/06/2023 | 09/06/2022 | 31/08/2021 |
| General meeting | 31/12/2025 | 07/07/2025 | 24/06/2024 | 01/06/2023 | 01/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 31/12/2025 | 12/01/2026 | Dutch | |
| Full model | 31/12/2024 | 07/07/2025 | 14/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 24/06/2024 | 09/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 01/06/2023 | 26/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 01/06/2022 | 09/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 01/06/2021 | 31/08/2021 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20258 active · 26 ended
Active mandates
Cohen Ezra
ActiveActive
Bpifrance Investissement SAS
ActiveGemayel Georges
ActiveSkinner Henry
ActiveActive
Mirabelli Christopher
ActiveDroller Rémi
ActiveEnded mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution31/03/2026RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
- Capital / shares03/07/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN
- Mandates22/01/2024ONTSLAGEN - BENOEMINGEN
- Capital / shares21/08/2023KAPITAAL - AANDELEN
- Capital / shares28/04/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates28/04/2023ONTSLAGEN - BENOEMINGEN
- Mandates20/04/2023DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Restructuring23/01/2023RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-13,4 M €↓
- 2024Annual accounts 2024-8,5 M €↑
- 2023Annual accounts 2023-10,8 M €↓
- 2022Annual accounts 2022-7,3 M €↓
- 2021Annual accounts 2021-2,4 M €↓
- 2020Annual accounts 2020-1,1 M €